Cargando…
The sweet and sour of serological glycoprotein tumor biomarker quantification
Aberrant and dysregulated protein glycosylation is a well-established event in the process of oncogenesis and cancer progression. Years of study on the glycobiology of cancer have been focused on the development of clinically viable diagnostic applications of this knowledge. However, for a number of...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3751898/ https://www.ncbi.nlm.nih.gov/pubmed/23390961 http://dx.doi.org/10.1186/1741-7015-11-31 |